Statistics about Health, Pharma & Medtech in Japan
Statistics
- JCR Pharmaceuticals Co., Ltd. operating profit 2020-2024
- JCR Pharmaceuticals Co., Ltd. net cash 2020-2024
- JCR Pharmaceuticals Co., Ltd. total equity 2020-2024
- H.U. Group Holdings, Inc. net income 2020-2024
- H.U. Group Holdings, Inc. liabilities 2020-2024
- H.U. Group Holdings, Inc. net cash 2020-2024
- H.U. Group Holdings, Inc. gross profit 2020-2024
- H.U. Group Holdings, Inc. revenue 2020-2024
- H.U. Group Holdings, Inc. total assets 2020-2024
- H.U. Group Holdings, Inc. operating profit 2020-2024
- H.U. Group Holdings, Inc. total equity 2020-2024
- Fuso Pharmaceutical Industries,Ltd. liabilities 2020-2024
- Fuso Pharmaceutical Industries,Ltd. net income 2020-2024
- Fuso Pharmaceutical Industries,Ltd. revenue 2020-2024
- Fuso Pharmaceutical Industries,Ltd. net cash 2020-2024
- Fuso Pharmaceutical Industries,Ltd. gross profit 2020-2024
- Fuso Pharmaceutical Industries,Ltd. total equity 2020-2024
- Fuso Pharmaceutical Industries,Ltd. total assets 2020-2024
- Fuso Pharmaceutical Industries,Ltd. operating profit 2020-2024
- FALCO HOLDINGS Co., Ltd. net income 2020-2024
- FALCO HOLDINGS Co., Ltd. liabilities 2020-2024
- FALCO HOLDINGS Co., Ltd. revenue 2020-2024
- FALCO HOLDINGS Co., Ltd. net cash 2020-2024
- FALCO HOLDINGS Co., Ltd. gross profit 2020-2024
- FALCO HOLDINGS Co., Ltd. operating profit 2020-2024
- FALCO HOLDINGS Co., Ltd. total assets 2020-2024
- FALCO HOLDINGS Co., Ltd. total equity 2020-2024
- Eisai Co., Ltd. net income 2020-2024
- Eisai Co., Ltd. liabilities 2020-2024
- Eisai Co., Ltd. revenue 2020-2024
- Eisai Co., Ltd. gross profit 2020-2024
- Eisai Co., Ltd. operating profit 2020-2024
- Eisai Co., Ltd. net cash 2020-2024
- Eisai Co., Ltd. total assets 2020-2024
- Eisai Co., Ltd. total equity 2020-2024
- Daito Pharmaceutical Co.,Ltd. liabilities 2020-2024
- Daito Pharmaceutical Co.,Ltd. revenue 2020-2024
- Daito Pharmaceutical Co.,Ltd. net income 2020-2024
- Daito Pharmaceutical Co.,Ltd. total assets 2020-2024
- Daito Pharmaceutical Co.,Ltd. gross profit 2020-2024
- Daito Pharmaceutical Co.,Ltd. net cash 2020-2024
- Daito Pharmaceutical Co.,Ltd. operating profit 2020-2024
- Daito Pharmaceutical Co.,Ltd. total equity 2020-2024
- Daiichi Sankyo Company, Limited net income 2020-2024
- Daiichi Sankyo Company, Limited revenue 2020-2024
- Daiichi Sankyo Company, Limited liabilities 2020-2024
- Daiichi Sankyo Company, Limited total assets 2020-2024
- Daiichi Sankyo Company, Limited gross profit 2020-2024
- Daiichi Sankyo Company, Limited total equity 2020-2024
- Daiichi Sankyo Company, Limited net cash 2020-2024
- Daiichi Sankyo Company, Limited operating profit 2020-2024
- Chugai Pharmaceutical Co., Ltd. net income 2020-2024
- BML, Inc. net income 2020-2024
- BML, Inc. revenue 2020-2024
- BML, Inc. liabilities 2020-2024
- BML, Inc. operating profit 2020-2024
- BML, Inc. gross profit 2020-2024
- BML, Inc. net cash 2020-2024
- BML, Inc. total assets 2020-2024
- BML, Inc. total equity 2020-2024
- Astellas Pharma Inc. net income 2020-2024
- Astellas Pharma Inc. revenue 2020-2024
- Astellas Pharma Inc. operating profit 2020-2024
- Astellas Pharma Inc. total assets 2020-2024
- Astellas Pharma Inc. liabilities 2020-2024
- Astellas Pharma Inc. net cash 2020-2024
- Astellas Pharma Inc. gross profit 2020-2024
- Astellas Pharma Inc. total equity 2020-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. liabilities 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. net income 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. net cash 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. revenue 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. gross profit 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. total equity 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. operating profit 2021-2024
- ASKA Pharmaceutical Holdings Co.,Ltd. total assets 2021-2024
- Prevalence of health conditions in Japan 2025
- AMED's R&D expenses FY 2017-2023
- CPI of medical services Japan 2015-2024
- Medical, healthcare, and welfare industry LPI Japan 2015-2024
- Torii Pharmaceutical Co., Ltd. net income 2020 to 2023
- Torii Pharmaceutical Co., Ltd. liabilities 2020 to 2023
- Torii Pharmaceutical Co., Ltd. revenue 2020 to 2023
- Torii Pharmaceutical Co., Ltd. net cash 2020 to 2023
- Torii Pharmaceutical Co., Ltd. gross profit 2020 to 2023
- Torii Pharmaceutical Co., Ltd. total assets 2020 to 2023
- Torii Pharmaceutical Co., Ltd. operating profit 2020 to 2023
- Torii Pharmaceutical Co., Ltd. total equity 2020 to 2023
- Santen Pharmaceutical Co., Ltd. net cash 2020 to 2023
- Pharma Foods International Co., Ltd. liabilities 2021 to 2024
- Pharma Foods International Co., Ltd. net income 2021 to 2024
- Pharma Foods International Co., Ltd. gross profit 2021 to 2024
- Pharma Foods International Co., Ltd. revenue 2021 to 2024
- Pharma Foods International Co., Ltd. net cash 2021 to 2024
- Pharma Foods International Co., Ltd. operating profit 2021 to 2024
- Pharma Foods International Co., Ltd. total equity 2021 to 2024
- Pharma Foods International Co., Ltd. total assets 2021 to 2024
- Koa Shoji Holdings Co.,Ltd. net income 2021 to 2024
- Koa Shoji Holdings Co.,Ltd. revenue 2021 to 2024
- Koa Shoji Holdings Co.,Ltd. liabilities 2021 to 2024